Aventis Pharma S A
USPTO Trademark & Patent Filings
Trademark applications and grants for Aventis Pharma S A. Aventis Pharma S A has 107 trademark applications. The latest application filed is for "ROVAMYCINE"
- Company Aliases
- Aventis Pharma S.A.
- AVENTIS PHARMA SA
- AVENTIS PHARMA S.A. - Antony FR
- Aventis Pharma S.A. - Antony FR
Trademarks Patents
| Patent Application | Date |
|---|---|
| ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN 20190275147 - 16/272315 BISSERY; Marie-Christine ; et al. | 2019-09-12 |
| NOVEL ANTITUMORAL USE OF CABAZITAXEL 20190151278 - 16/251143 GUPTA; Sunil | 2019-05-23 |
| CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING THE SAME 20190144406 - 16/188687 BILLOT; Pascal ; et al. | 2019-05-16 |
| ANTITUMORAL COMBINATION COMPRISING CABAZITAXEL AND CISPLATIN 20180153931 - 15/648930 BISSERY; Marie-Christine ; et al. | 2018-06-07 |
| NOVEL ANTITUMORAL USE OF CABAZITAXEL 20180125810 - 15/627962 GUPTA; Sunil | 2018-05-10 |
| NCAGE Code | F2608 | AVENTIS PHARMA S.A |
| NCAGE Code | B0484 | AVENTIS PHARMA SA |
| CAGE Code | B0484 | AVENTIS PHARMA SA |
| CAGE Code | F2608 | AVENTIS PHARMA S.A |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 